Cross-sectional and prospective associations between abdominal adiposity and proinsulin concentration

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 1, 2002, Pages 77-83

  Hanley, Anthony J G ^a,b   McKeown Eyssen, Gail ^e   Harris, Stewart B ^b   Hegele, Robert A ^c   Wolever, Thomas M S ^d   Kwan, Jeremy ^a   Zinman, Bernard ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; PROINSULIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT; BODY HEIGHT; BODY WEIGHT; CANADA; CELL FUNCTION; CONTROLLED STUDY; DISEASE ASSOCIATION; EPIDEMIC; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; WORLD HEALTH ORGANIZATION;

EID: 0036148029     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.1.8139     Document Type: Article

References (65)

1. Insulin resistance versus insulin deficiency in non-insulin dependent diabetes mellitus: Problems and prospects
2. The genetic basis of type 2 diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity
3. What β-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin processing mechanism
4. Hyperproinsulinaemia and amyloid in NIDDM: Clues to the etiology of islet beta cell function?
5. Disproportionately elevated proinsulin in Pima Indians with non-insulin-dependent diabetes mellitus
6. Hyperinsulinaemia in obesity is not accompanied by an increase in serum proinsulin/insulin ratio in groups of human subjects with and without glucose intolerance
7. Raised proinsulin concentration as early indicator of beta-cell dysfunction
8. Proinsulin and specific insulin concentrations in high and low risk populations for NIDDM
9. Hyperproinsulinaemia of type II diabetes is not present before the development of hyperglycemia
10. Higher proinsulin and specific insulin are both associated with a parental history of diabetes in nondiabetic Mexican American subjects
11. Relationship of proinsulin and insulin with non-insulin-dependent diabetes and coronary heart disease in Japanese American men: Impact of obesity - Clinical Research Center Study
12. Proinsulin and insulin levels according to glucose tolerance among Japanese-Brazilians, age 40-79 years
13. Plasma insulin. C-peptide, and proinsulin concentrations in obese and non-obese individuals with varying degrees of glucose intolerance
14. Abnormalities in fasting circulating proinsulin concentration in mild gestational diabetes
15. Total immunoreactive proinsulin, immunoreactive insulin, and specific insulin in relation to conversion to type 2 diabetes: The Mexico City Diabetes Study
16. Proinsulin as a marker for the development of type 2 diabetes in Japanese-American men
17. A higher proinsulin response to glucose loading predicts deteriorating fasting plasma glucose and worsening to diabetes in subjects with impaired glucose tolerance
18. Fasting proinsulin and 2-h post-load glucose levels predict the conversion to type 2 diabetes in subjects with impaired glucose tolerance: The Hoorn study
19. Serum proinsulin levels are disproportionately in early prediabetic subjects
20. Fasting proinsulin concentrations predict the development of type 2 diabetes
21. The relation of proinsulin, insulin and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycaemic subjects
22. The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: The Insulin Resistance Atherosclerosis Study
23. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM
24. The relationship of concentrations of insulin, intact proinsulin, and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects
25. Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjects
26. Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects - Evidence a modulating effect of insulin
27. The relationship of concentrations of insulin and proinsulin-like molecules with coronary heart disease prevalence and incidence: A study of two ethnic groups
28. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women
29. A single threshold value of waist girth identifies normal weight and overweight subjects with excess visceral adipose tissue
30. Influence of body fat distribution on free fatty acid metabolism in obesity
31. Postprandial free fatty acid kinetics are abnormal in upper body obesity
32. Body fat distribution, insulin mediated suppression of non-esterified fatty acids and plasma triglycerides in obese subjects
33. Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes
34. Free fatty acids and pathogenesis of type 2 diabetes mellitus
35. The Sandy Lake Health and Diabetes Project: Design, methods and lessons learned
36. The prevalence of NIDDM and associated risk factors in aboriginal Canadians
37. The impact of diabetes on cardiovascular risk factors and outcomes in a Native Canadian population
38. Are subarctic Indians undergoing the epidemiologic transition?
39. Prevalence of non-insulin-dependant diabetes mellitus and impaired glucose tolerance in two Algonquin communities in Quebec
40. A rapid and sensitive radioimmunoassay for the measurement of proinsulin in human serum
41. Structural domains and molecular lifestyles of insulin and its precursors in the pancreatic beta cell
42. Usefulness of bioelectrical impedance analysis in a population-based study of diabetes among Native Canadians
43. Usefulness of bioelectrical impedance analysis for measurement of body fat
44. Bioimpedance analysis: Evaluation of a leg-to-leg system based on pressure contact foot-pad electrodes
45. Bioelectrical impedance analysis (BIA) using bipolar foot electrodes in the assessment of body composition in type 2 diabetes mellitus
46. Estimation of insulin secretion rates from C-peptide levels: Comparison of individual and standard kinetic parameters for C-peptide clearance
47. Spurious correlation and the fallacy of the ratio standard revisited
48. Statistical considerations regarding the use of ratios to adjust data
49. The effect of exogenous hyperinsulinaemia on proinsulin secretion in normal man, obese subjects, and patients with insulinoma
50. Insulin propeptides in conditions associated with insulin resistance in humans and their relevance to insulin measurements
51. Does intra-abdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin-sensitive?
52. Insulin resistance and obesity: The role of fat distribution pattern
53. Lipotoxicity in the pathogenesis of obesity dependent NIDDM
54. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: Impairment of adipocyte-beta cell relationships
55. Role of nitric oxide in obesity-induced beta-cell disease
56. Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes
57. Chronic exposure to free fatty acid reduces pancreatic beta-cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation
58. Long term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta cell line MIN6
59. Diseases of liporegulation: New perspective on obesity and related disorders
60. Endocytosis of low-density lipoprotein by human pancreatic beta cells and uptake in lipid-storing vesicles, which increase with age
61. Insulin resistance does not change the ratio of proinsulin to insulin in normal volunteers
62. Hyperproinsulinaemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes